UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of December 2021
Commission File Number: 001-39997
Adagene Inc.
(Exact Name of Registrant as Specified in Its Charter)
4F, Building C14, No. 218
Xinghu Street, Suzhou Industrial Park
Suzhou, Jiangsu Province, 215123
People’s Republic of China
+86-512-8777-3632
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Adagene Inc. |
| | | |
| | By: | /s/ Peter (Peizhi) Luo |
| | Name: Peter (Peizhi) Luo |
| | Title: Chief Executive Officer |
| | |
| Date: December 7, 2021 | |
EXPLANTORY NOTE
Exhibit 99.1 to this Current Report on Form 6-K is the re-issued press release regarding data presentations at ESMO-IO in order to include more details about its presentation and shall supersede and replace the press release in the Exhibit 99.1 to the Current Report on Form 6-K dated December 6, 2021.
EXHIBIT INDEX
